POHL DAVID 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Feb 3, 2010
Insider Transaction Report
Form 4
POHL DAVID
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2010-02-01+250,000→ 370,000 totalExercise: $2.93Exp: 2020-02-11→ Common Stock (250,000 underlying)
Holdings
- 2,000
Common Stock, $.001 par value
Footnotes (2)
- [F1]Option will vest quarterly in equal installments over a two year period.
- [F2]n/a